Susquehanna International Group, LLP Novo Cure LTD Put Options Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

Put Options

29 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$15.61 - $23.34 $157,661 - $235,734	10,100 Added 6.95%	155,500 $2.43 Million
Q2 2024 Aug 15, 2024	SELL	$11.83 - $24.05 $1.12 Million - $2.28 Million	-94,700 Reduced 39.44%	145,400 $2.49 Million
Q1 2024 May 07, 2024	SELL	$12.42 - $17.29 $1.83 Million - $2.55 Million	-147,300 Reduced 38.02%	240,100 $3.75 Million
Q4 2023 Feb 14, 2024	BUY	$11.13 - $15.78 $3.83 Million - $5.43 Million	344,200 Added 796.76%	387,400 $5.78 Million
Q3 2023 Nov 14, 2023	SELL	$16.15 - $42.35 $3.31 Million - $8.69 Million	-205,100 Reduced 82.6%	43,200 $697,000
Q2 2023 Aug 11, 2023	BUY	$40.29 - $82.51 $6.27 Million - $12.8 Million	155,600 Added 167.85%	248,300 $10.3 Million
Q1 2023 May 16, 2023	SELL	$56.44 - $118.81 $7.22 Million - $15.2 Million	-128,000 Reduced 58.0%	92,700 $5.57 Million
Q4 2022 Feb 14, 2023	BUY	$63.98 - $85.37 $4.94 Million - $6.59 Million	77,200 Added 53.8%	220,700 $16.2 Million
Q3 2022 Nov 14, 2022	SELL	$67.99 - $89.57 $3.34 Million - $4.4 Million	-49,100 Reduced 25.49%	143,500 $10.9 Million
Q2 2022 Aug 15, 2022	BUY	$56.6 - $89.9 $2.49 Million - $3.96 Million	44,000 Added 29.61%	192,600 $13.4 Million
Q1 2022 May 16, 2022	SELL	$60.15 - $84.52 $1.51 Million - $2.12 Million	-25,100 Reduced 14.45%	148,600 $12.3 Million
Q4 2021 Feb 14, 2022	SELL	$75.08 - $121.99 $14.4 Million - $23.4 Million	-191,800 Reduced 52.48%	173,700 $13 Million
Q3 2021 Nov 15, 2021	BUY	$116.17 - $194.55 $29.4 Million - $49.3 Million	253,400 Added 226.05%	365,500 $42.5 Million
Q2 2021 Aug 11, 2021	SELL	$130.4 - $225.58 $3.93 Million - $6.79 Million	-30,100 Reduced 21.17%	112,100 $24.9 Million
Q1 2021 May 17, 2021	SELL	$124.11 - $190.17 $28 Million - $42.9 Million	-225,800 Reduced 61.36%	142,200 $18.8 Million
Q4 2020 Feb 16, 2021	BUY	$112.16 - $174.14 $717,824 - $1.11 Million	6,400 Added 1.77%	368,000 $63.7 Million
Q3 2020 Nov 16, 2020	SELL	$58.05 - $111.31 $7.57 Million - $14.5 Million	-130,400 Reduced 26.5%	361,600 $40.3 Million
Q2 2020 Aug 14, 2020	BUY	$57.2 - $74.41 $4.24 Million - $5.51 Million	74,100 Added 17.73%	492,000 $29.2 Million
Q1 2020 May 15, 2020	BUY	$57.05 - $95.75 $9.65 Million - $16.2 Million	169,200 Added 68.03%	417,900 $28.1 Million
Q4 2019 Feb 14, 2020	BUY	$68.3 - $93.8 $2.88 Million - $3.96 Million	42,200 Added 20.44%	248,700 $21 Million
Q3 2019 Nov 14, 2019	BUY	$61.86 - $97.8 $2.75 Million - $4.34 Million	44,400 Added 27.39%	206,500 $15.4 Million
Q2 2019 Aug 14, 2019	BUY	$42.22 - $63.23 $4.57 Million - $6.84 Million	108,200 Added 200.74%	162,100 $10.3 Million
Q1 2019 May 15, 2019	SELL	$31.96 - $56.12 $297,228 - $521,916	-9,300 Reduced 14.72%	53,900 $2.6 Million
Q4 2018 Feb 14, 2019	SELL	$28.72 - $52.63 $298,688 - $547,352	-10,400 Reduced 14.13%	63,200 $2.12 Million
Q3 2018 Nov 14, 2018	BUY	$32.0 - $52.4 $300,800 - $492,560	9,400 Added 14.64%	73,600 $3.86 Million
Q2 2018 Aug 14, 2018	SELL	$19.85 - $32.0 $772,165 - $1.24 Million	-38,900 Reduced 37.73%	64,200 $2.01 Million
Q1 2018 May 15, 2018	SELL	$19.3 - $23.65 $476,710 - $584,155	-24,700 Reduced 19.33%	103,100 $2.25 Million
Q4 2017 Feb 14, 2018	SELL	$16.3 - $21.9 $567,240 - $762,120	-34,800 Reduced 21.4%	127,800 $2.58 Million
Q3 2017 Nov 14, 2017	BUY	$18.05 - $21.75 $2.93 Million - $3.54 Million	162,600	162,600 $3.23 Million

Others Institutions Holding NVCR

# of Institutions

263

Shares Held

77M

Call Options Held

1.17M

Put Options Held

318K

Black Rock Inc. New York, NY

12.1M
Shares

$389 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

11.8M
Shares

$380 Million
0.0% of portfolio
Capital International Investors Los Angeles, CA

7.92M
Shares

$254 Million
0.02% of portfolio
Capital World Investors Los Angeles, CA

4.31M
Shares

$138 Million
0.01% of portfolio
Nordwand Advisors, LLC Radnor, PA

3.03M
Shares

$97.3 Million
12.67% of portfolio

View Full List

About NovoCure Ltd

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $3.37B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

More about NVCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account